Molecular genetics of dopa-responsive dystonia

Biological Chemistry

Volumn 380, Issue 12, 1999, Pages 1355-1364

  Ichinose, Hiroshi ^a   Suzuki, Takahiro ^a   Inagaki, Hidehito ^a   Ohye, Tamae ^a   Nagatsu, Toshiharu ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Dopa responsive dystonia; GTP cyclohydrolase I; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; MESSENGER RNA; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE;

ALLELE; AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 11P; CHROMOSOME 14Q; DOPAMINE METABOLISM; DYSTONIA; ENZYME ACTIVITY; EXON; FRAMESHIFT MUTATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; HUMAN; INTRON; MISSENSE MUTATION; MOLECULAR CLONING; MOLECULAR GENETICS; MONONUCLEAR CELL; NIGRONEOSTRIATAL SYSTEM; NONSENSE MUTATION; PARKINSONISM; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

EID: 0033376984     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.175     Document Type: Review

References (78)

1. Bandmann, O., Nygaard, T.G., Surtees, R., Marsden, C.D., Wood, N.W., and Harding, A.E. (1996). Dopa-responsive dystonia in British patients: new mutations of the GTP cyclohydroxylase I gene and evidence for genetic heterogeneity. Hum. Mol. Genet. 5, 403-406.
2. Bandmann, O., Valente, E.M., Holmans, P., Surtees, R.A.H., Walters, J.H., Wevers, R.A., Marsden, C.D., and Wood, N.W. (1998). Dopa-responsive dystonia: a clinical and molecular genetic study. Ann. Neurol. 44, 649-656.
3. Bartholomé, K., and Lüdecke, B. (1998). Mutations in the tyrosine hydroxylase gene cause various forms of L-dopa responsive dystonia. Advances in Pharmacology, Catecholamines: Bridging Basic Science with Clinical Medicine, D. Goldstein, G. Eisenhofer, and R. McCarty, eds. (New York: Academic Press), pp. 48-49.
4. Beyer, K., Ladoniga, J.-V., Beeino-Bilbao, B., Cababelos, R., and de la Fuente-Fernández, R. (1997). A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive, and dopa responsive dystonia. Lancet 349, 420-421.
5. Bezin, L., Nygaard, T.G., Neville, J.D., Shen, H., and Levin, R.A. (1998). Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia. Neurology 50, 1021-1027.
6. Blau, N., Joller, P., Atarés, M., Cardesa-Garcia, J., and Niederwieser, A. (1983). Increase of GTP cyclohydrolase I activity in mononuclear blood cells by stimulation: detection of heterozygotes of GTP cyclohydrolase I deficiency. Clin. Chim. Acta 148, 47-52.
7. Bräutigam, C., Wevers, R.A., Jansen, R.J.T., Smeitink, J.A.M., de Rijk-van Andel, J.F., Gabreëls, F.J.M., and Hoffmann, G.F. (1998). Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin. Chem. 44, 1897-1904.
8. Briqtie, S., Chartiar-Harlin, M.C., Dhondt, J.L., Delacourta, A., and Desle, A. (1997). A new mutation of GTP cyclohydrolase I gene causative of dopa-responsive dystonia in French family. Movement Disorder 12, Suppl. 1, 253.
9. Deuschl, G., Benecke, R., Martinius, J., and Müller, U. (1998). High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia. Ann. Neurol. 43, 634-639.
10. de la Fuente-Fernández, R. (1998). Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia. Neurology 50, 1134-1135.
11. Dumas, S., Le Hir, H., Bodeau-Péan, S., Hirsch, E., Thermes, C., and Mallet, J. (1996). New species of human tyrosine hydroxylase mRNA are produced in variable amounts in adrenal medulla and are overexpressed in progressive supranuclear palsy. J. Neurochem. 67, 19-25.
12. Fink, J.K., Barton, N., Cohen, W., Lovenberg, W., Burns, R.S., and Hallett, M. (1988). Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 38, 707-711.
13. Flatmark, T., Knappskog, P.M., Bjørgo, E., and Martinez, A. (1997). Molecular characterization of disease related mutant of human phenylalanine hydroxylase and tyrosine hydroxylase. Pteridines 8, 58-59.
14. Flatmark, T., and Stevens, R.C. (1997). Structural insight into the aromatic amino acid hydroxylases and their disease-related mutant forms. Chem. Rev. 99, 2137-2160.
15. Furukawa, Y., Nishi, K., Kondo, T., Mizuno, Y., and Narabayashi, H. (1993). CSF biopterin levels and clinical features of patients with juvenile parkinsonism. In: Advances in Neurology, Vol. 60, H. Narabayashi, T. Nagatsu, N. Yanagisawa and Y. Mizuno, eds. (New York, USA: Raven Press), pp. 562-567.
16. Furukawa, Y., Shimadzu, M., Rajput, A.H., Shimizu, Y., Tagawa, T., Mori, H., Yokochi, M., Narabayashi, H., Hornykiewicz, O., Mizuno, Y., and Kishi, S.J. (1996). GTP cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann. Neurol. 39, 609-617.
17. Furukawa, Y., Kishi, S.J., Babin, E.M., Jacobson, R.D., Fryburg, J.S., Wilson, W.G., Shimadzu, M., Hyland, K., and Trugman, J.M. (1998a). Dystonia with motor delay in compound heterozygotes for GTP-cyclohydroxylase I gene mutations. Ann. Neurol. 44, 10-16.
18. Furukawa, Y., Lang, A.E., Trugman, J.M., Bird, T.D., Hunter, A., Sadeh, M., Tagawa, T., St. George-Hystop, P.H., Gutman, M., Morris, L.W., Hornykiewicz, O., Shimadzu, M., and Kish, S.J. (1998b). Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology 50, 1015-1020.
19. Görke, W., and Bartholomé, K. (1990). Biochemical and neurophysiological investigation in two forms of Segawa's disease. Neuropediatrics 21, 3-8.
20. Grima, B., Lamouroux, A., Boni, C., Julian, J.-F., Javoy-Agid, F., and Mallet, J. (1987). A single human gene encoding multiple tyrosine hydroxylase with different predicted functional characteristics. Nature 326, 707-711.
21. Hirano, M., Tamaru, Y., Nagai, Y., Ito, H., Imai, T., and Ueno, S. (1995). Exon skipping caused by a base substitution at a splice in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa responsive dystonia. Biochem. Biophys. Res. Commun. 213, 645-651.
22. Hirano, M., Tamaru, Y., Ito, H., Matsumoto, S., Imai, T., and Ueno, S. (1996). Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia. Ann. Neurol. 40, 796-798.
23. Hirano, M., Imaiso, Y., and Ueno, S. (1997). Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Biochem. Biophys. Res. Commun. 234, 316-319.
24. Hirano, M., Yanagihara, T., and Ueno, S. (1998). Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia. Ann. Neurol. 44, 365-371.
25. Hirayama, K., and Kapatos, G. (1998). Nigrostriatal dopamine neurons express low levels of GTP cyclohydrolase I protein. J. Neurochem. 70, 164-170.
26. Hyland, K., Fryburg, J.S., Wilson, W.G., Bebin, E.M., Arnold, L.A., Gunasekera, R.S., Jacobson, R.D., Rost-Ruffner, E., and Trugman, J.M. (1997). Oral phenylalanine loading in dopa-respon-sive dystonia: a possible diagnostic test. Neurology 48, 1290-1297.
27. Ichikawa, S., Sasaoka, T., and Nagatsu, T. (1991). Primary structure of mouse tyrosine hydroxylase deduced from its cDNA. Biochem. Biophys. Res. Commun. 176, 1610-1616.
28. Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1994). Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet. 8, 236-242.
29. Ichinose, H., Ohye, T., Matsuda, Y., Hori, T., Blau, N., Burlina, A., Rouse, B., Mutalon, R., Fujita, K., and Nagatsu, T. (1995a). Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J. Biol. Chem. 276, 10062-10071.
30. Ichinose, H., Ohye, T., Segawa, M., Nomura, Y., Endo, T., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1995b). GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci. Lett. 196, 5-8.
31. Ichinose, H., Ohye, T., Yokochi, M., Fujita, K., and Nagatsu, T. (1995c). GTP cyclohydrolase I activity in mononuclear blood cells in juvenile parkinsonism. Neurosci. Lett. 190, 140-142.
32. Illarishkin, S.W., Markova, E.D., Slominsky, P.A., Mjklina, N.I., Popova, S.N., Limborska, S.A., Tsuji, S., and IvanovaSmolens, I.A. (1998). The GTP cyclohydrolase I gene in Russian families with dopa-responsive dystonia. Arch. Neurol. 53, 789-792.
33. Imaiso, Y., Taniwaki, T., Yamada, T., Yoshimura, T., Hirano, M., Ueno, S., Kaneda, N., and Kira, J. (1998). A novel mutation of the GTP-cyclohydrolase I gene in a patient with hereditary progressive dystonia/dopa-responsive dystonia. Neurology 50, 517-519.
34. Inagaki, H., Ohye, T., Suzuki, T., Segawa, M., Nomura, Y., Nagatsu, T., and Ichinose, H. (1999). Decrease in GTP cyclohydrolase I gene expression caused by inactivation of one allele in hereditary progressive dystonia with marked diurnal fluctuation. Biochem. Biophys. Res. Commun. 260, 747-751.
35. Iwata, N., Kobayashi, K., Sasaoka, T., Hidaka, H., and Nagatsu, T. (1992). Structure of the mouse tyrosine hydroxylase gene. Biochem. Biophys. Res. Commun. 182, 348-354.
36. Jarman, P.R., Bandmann, O., Marsdan, C.D., and Wood, N.W. (1997). GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs. J. Neurol. Neurosurg. Psychiatry 63, 304-308.
37. Kaneda, N., Kobayashi, K., Ichinose, H., Kishi, F., Nakazawa, A., Kurosawa, Y., Fujita, K., and Nagatsu, T. (1987). Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem. Biophys. Res. Commun. 146, 971-975.
38. Kaufman, S. (1963). The structure of the phenylalanine hydroxylase cofactor. Proc. Natl. Acad. Sec. USA 50, 1085-1093.
39. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 329, 605-608.
40. Klein, C., Brin, M.F., de Leon, D., Limborska, S.A., Ivanova-Smolenskaya, I.A., Bressman, S.B., Friedman, A., Markova, E.D., Risch, N.J., Breakfield, X.O., and Ozelius, L.J. (1998). De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia. Hum. Mol. Genet. 7, 1133-1136.
41. Knappskog, P.M., Flatmark, T., Mallet, J., Lüdecke, B., and Bartholomé, K. (1995). Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q 381 K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 1209-1212.
42. Kobayashi, K., Kaneda, N., Ichinose, H., Kishi, F., Nakazawa, A., Kurosawa, Y., Fujita, K., and Nagatsu, T. (1988). Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J. Biochem. 103, 907-912.
43. Kwon, N.S., Nathan, C.F., and Stuehr, D.J. (1987). Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J. Biol. Chem. 264, 20496-20501.
44. Le Boudellés, B., Boularand, S., Boni, C., Horellou, P., Dumas, S., Grima, B., and Mallet, J. (1988). Analysis of the 5′-region of the human tyrosine hydroxylase gene: combinatorial patterns of exon splicing generate multiple tyrosine hydroxylase isoforms. J. Neurochem. 50, 988-991.
45. Levitt, M., Spector, S., Sjoerdsma, A., and Udenfriend, S. (1965). Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J. Pharmacol. Exp. Therap 148, 1-8.
46. Lewitt, P.A., Miller, L.P., Levine, R.A., Lovenberg, W., Newman, R.P., Papavasiliou, A., Rayes, A., Eldridge, R., and Burns, R.S. (1986). Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials. Neurology 36, 760-764.
47. Lovenberg, W., Jequir, E., and Sjoerdsma, A. (1967). Tryptophan hydroxylase: measurement in pineal gland, brain stem, and carcinoid tumor. Science 155, 217-219.
48. Lüdecke, B., and Bartholomé, K. (1995). Frequent sequence variant in the human tyrosine hydroxylase gene. Human Genet. 95, 716.
49. Lüdecke, B., Dworniczak, B., and Bartholomé, K. (1995). A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum. Genet. 95, 123-125.
50. Lüdecke, B., Knappskog, P.M., Clayton, P.T., Surtees, R.A.H., Clelland, J.D., Heales, S.J.R., Brand, M.P., Bartholomé, K., and Flatmark, T. (1996). Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 5, 1023-1028.
51. Müller, U., Weber, Y., and Martinitus, J. (1998). High penetrance and remarkable variation in expression of GCH 1 mutations in German DRD families. Ann. J. Human Genet. 61, Suppl. A, 341.
52. Nagatsu, T. (1991). Genes for human catecholamine-synthesizing enzymes. Neurosci. Res. 12, 315-345.
53. Nagatsu, T., Levitt, M., and Udenfriend, S. (1964). Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 239, 2910-2917.
54. Nagatsu, T., and Ichinose, H. (1991). Comparative studies on the structure of tyrosine hydroxylase with those of the enzyme of various mammals. Comp. Biochem. Physiol. 98C, 203-210.
55. Nagatsu, T., and Ichinose, H. (1998). Genetic basis of dominant dystonia. Advances in Pharmacology, Catecholamines Bridging Basic Science with Clinical Medicine, D. Goldstein, G. Eisenhofer, and R. McCarty, eds. (New York: Academic Press), pp. 44-47.
56. Nagatsu, T., and Ichinose, H. (1999). Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin. Mol. Neurobiol. 19, 79-96.
57. Nagatsu, T., Ichinose, H., Mogi, M., and Togari, A. (1999). Neopterin and cytokines in hereditary dystonia and Parkinson's disease. Pteridines 10, 5-13.
58. Niederwieser, A., Blau, N., Wang, M., Joller, P., Antarés, M., and Cardesa-Garcia, J. (1984). GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur. J. Pediatr. 141, 208-214.
59. Nitschke, M., Steinberger, D., Heberlein, I., Otto, V., Müller, U., and Vieregge, P. (1998). Dopa responsive dystonia with Turner's syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP cyclohydrolase I gene. J. Neurol. Neurosurg. Psychiatry 64, 806-808.
60. Nygaard, T.G., Marsden, C.D., and Duvoisin, R.C. (1988). Dopa-responsive dystonia. In: Advances in Neurology, Vol. 50, S. Fahn, C.D. Marsden and D.B. Calne, eds. (New York, USA: Raven Press), pp. 377-384.
61. Nygaard, T.G., Snow, B.J., Fahn, S., and Calne, D.B. (1993a). Dopa-responsive dystonia: clinical characteristics and definition. In: Hereditary Progressive Dystonia with Marked Diurnal Fluctuation, Segawa, M. ed. (Carnforth, UK: Parthenon), pp. 21-35.
62. Nygaard, T.G., Wilhelmsen, K.C., Risch, N.J., Brown, D.L., Trugman, J.M., Gilliam, T.C., Fahn, S., and Weeks, D.E. (1993b). Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nature Genet. 5, 386-390.
63. Ozelius, L.J., and Breakfield, X.O. (1994). Cofactor insufficiency in dystonia-parkinsonian syndrome. Nature Genet. 8, 207-209.
64. Ozelius, L.J., Hewett, J.W., Page, C.E., Bressman, S.B., Kramer, P.L., Shalish, C., deLeon, D., Brin, M.F., Raymond, D., Corey, D.P., Fahn, S., Risch, N.J., Buckler, A.J., Gusella, J.F., and Breakfield, X.O. (1997). The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nature Genet. 17, 40-48.
65. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I., and Nussbaum, R.L. (1997). Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
66. Sasaki, R., Naito, Y., and Kuzuhara, Z. (1998). A novel de novo point mutation in the GTP cyclohydrolase I gene in a Japanese patient with hereditary progressive and dopa responsive dystonia. J. Neurol. Neurosurg. Psychiatry 65, 947-949.
67. Segawa, M., Ohmi, K., Itoh, S., Aoyama, M., and Hayakawa, H. (1971). Childhood basal ganglia disease with remarkable response to L-dopa, hereditary basal ganglia disease with marked diurnal fluctuation. Shinryo (Tokyo) 24, 667-672.
68. Segawa, M., Hosoya, A., Miyagawa, F., Nomura, Y., Imai, H. (1976). Hereditary progressive dystonia with marked diurnal fluctuation. In: Advances in Neurology, Vol. 14, R. Eldridge and S. Fahn, eds. (New York, USA: Raven Press), pp. 215-233.
69. Suzuki, T., Ohye, T., Inagaki, H., Nagatsu, T., and Ichinose, H. (1999). Characterization of wild-type and mutants of recombinant human GTP cyclohydrolase I. In relation to etiology of dopa-responsive dystonia. J. Neurochem., in press.
70. Steinberger, D., Weber, Y., Korinthenberg, R., Deuschl, G., Benecke, R., Martinius, R., and Müller, U. (1998). High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia. Ann. Neurol. 43, 634-639.
71. Tamaru, Y., Hirano, M., Ito, H., Kawamura, J., Matsumoto, S., Imai, T., and Ueno, S. (1998). Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene. J. Neurol. Neurosurg. Psychiatry 64, 469-473.
72. Tanaka, H., Endo, K., Tsuji, S., Nygaard, T.G., Weeks, D.E., Nomura, Y., and Segawa, M. (1995). The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q. Ann. Neurol. 37, 405-408.
73. Takahashi, H., Levine, R.A., Galloway, M.P., Snow, B.-J., Calne, D.B., and Nygaard, T.G. (1994). Biochemical and fluorodopa position emission tomographic finding in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann. Neurol. 35, 354-356.
74. Tayeh, M.A., and Marietta, M.A. (1989). Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264, 19654-19658.
75. Thöny, B., and Blau, N. (1997). Mutations in the GTP-cyclohydrolase I and 6-pyruvoyltetrahydropterin synthase genes. Hum. Mutat. 10, 11-20.
76. van den Heuvel, L.R.W.J., Luitin, B., Smeitink, J.A.M., de Rijk-van Andel, J.F., Hyland, K., Steenbergen-Spanjers, G.C.H., Janssen, R.J.T., and Wevers, R.A. (1998). A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population. Hum. Genet. 102, 644-646.
77. Williams, A., Eldridge, R., Levine, R., Lovenberg, W., and Paulson, G. (1979). Low CSF hydroxylase cofactor(tetrahydrobiopterin) levels in inherited dystonia. Lancet 2, 410-411.
78. Zhou, Q.-Y., Quaife, C.J., and Palmiter, R.D. (1995). Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374, 640-643.